# Evidence reviewer — This GLP | This GLP

This GLP coverage of what the trials measured, in whom, at what dose, and for how long. Browse sourced articles and the publisher’s editorial standards.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/authors/dana-sullivan
Updated: 2026-09-15

[← Editorial team](https://thisglp.com/authors)

Coverage area

# Evidence reviewer

This GLP articles covering Randomized trial design and endpoints, FDA prescribing information and label changes, Reported adverse events and dropout rates, Dose-response and titration schedules, Compounded versus FDA-approved formulations, Reading a study's limitations section.

Published by This GLP Editorial Team. This collection brings together sourced articles on what the trials measured, in whom, at what dose, and for how long. These pages explain available evidence; they do not provide a clinical opinion or claim firsthand treatment experience.

## Coverage

-   Randomized trial design and endpoints
-   FDA prescribing information and label changes
-   Reported adverse events and dropout rates
-   Dose-response and titration schedules
-   Compounded versus FDA-approved formulations
-   Reading a study's limitations section

## Articles in this collection

77 pieces

-   [Does Ozempic Lower Cholesterol? What the Lipid Results in the Trials Show Evidence](https://thisglp.com/research/does-ozempic-lower-cholesterol)
-   [Does Tirzepatide Cause Skin Sensitivity? The Allodynia Reports, Counted Safety](https://thisglp.com/research/does-tirzepatide-cause-skin-sensitivity)
-   [Should You Stop Ozempic Before a Colonoscopy? What Bowel-Prep Studies Found Safety](https://thisglp.com/research/should-you-stop-ozempic-before-a-colonoscopy)
-   [Where Should You Inject Ozempic? Abdomen, Thigh or Arm Gave the Same Exposure Formats](https://thisglp.com/research/where-should-you-inject-ozempic)
-   [How Long Does Zepbound Stay in Your System? About a Month Safety](https://thisglp.com/research/how-long-does-zepbound-stay-in-your-system)
-   [How Do You Avoid Ozempic Face? No Tested Way to Prevent It Safety](https://thisglp.com/research/how-to-avoid-ozempic-face)
-   [Do GLP-1 Drugs Cause Depression or Anxiety? The Trials Say No, the Records Say Yes Safety](https://thisglp.com/research/do-glp1-drugs-cause-depression)
-   [GLP-1 Drugs in Pregnancy: What the Evidence Shows, and What It Cannot Safety](https://thisglp.com/research/glp1-in-pregnancy-what-the-evidence-shows)
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?Evidence](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
-   [Is CagriSema Better Than Semaglutide Alone? By 6.5 Points, Head to Head Evidence](https://thisglp.com/research/is-cagrisema-better-than-semaglutide)
-   [Do GLP-1 Drugs Prevent Stroke? The Composite Moves, Stroke Alone Is Thin Evidence](https://thisglp.com/research/do-glp1-drugs-prevent-stroke)
-   [Retatrutide in Type 2 Diabetes: Why TRANSCEND-T2D-1 Reads Lower Than Phase 2 Evidence](https://thisglp.com/research/retatrutide-transcend-t2d-1)
-   [Survodutide: What SYNCHRONIZE-1 Found, and Why It Reads Weaker Than Phase 2 Evidence](https://thisglp.com/research/survodutide-synchronize-1)
-   [Ozempic Teeth: What Has Actually Been Measured, and What Has Not Safety](https://thisglp.com/research/ozempic-teeth)
-   [Do GLP-1 Drugs Prevent Heart Attacks and Strokes? One, Not Both Evidence](https://thisglp.com/research/do-glp1-drugs-prevent-heart-attacks-and-strokes)
-   [Weight-Loss Drugs in Hypertension: What the Cochrane Review Lacked Evidence](https://thisglp.com/research/eight-trials-and-nobody-counted-the-deaths)
-   [Does Semaglutide Help Liver Cirrhosis? Not in the Trial That Tested It Evidence](https://thisglp.com/research/does-semaglutide-help-liver-cirrhosis)
-   [Can You Take a GLP-1 With Epilepsy? Seizure Risk Did Not Rise Evidence](https://thisglp.com/research/can-you-take-a-glp1-with-epilepsy)
-   [How Many Heart Attacks Could Semaglutide Prevent in the US?Evidence](https://thisglp.com/research/how-many-heart-attacks-could-semaglutide-prevent)
-   [GLP-1 Use and Knee Replacement: Absolute Risk at Eight Years Evidence](https://thisglp.com/research/fewer-knee-replacements-eight-years-on)
-   [Does Orforglipron Work for Type 2 Diabetes? Three Phase 3 Trials Evidence](https://thisglp.com/research/does-orforglipron-work-for-type-2-diabetes)
-   [Respiratory Side Effects of Weight-Loss Drugs: A Review of 123 Studies Safety](https://thisglp.com/research/one-asthma-study-in-a-hundred-and-twenty-three)
-   [Is There a GLP-1 Pill That Works? Two Tablets, Two Different Answers Formats](https://thisglp.com/research/does-the-glp1-pill-work-as-well-as-the-injection)
-   [Mortality in Serious Mental Illness: GLP-1 vs SGLT2 Inhibitors Evidence](https://thisglp.com/research/a-mortality-gap-in-serious-mental-illness)
-   [Can a Drug Prevent Muscle Loss on a GLP-1? Two Antibodies Tested Evidence](https://thisglp.com/research/can-a-drug-prevent-muscle-loss-on-a-glp1)
-   [What Is Ecnoglutide? A Phase 3 Result You Cannot Compare to the Others Evidence](https://thisglp.com/research/what-is-ecnoglutide)
-   [Tirzepatide vs Semaglutide for Heart Failure, With and Without Diabetes Evidence](https://thisglp.com/research/bigger-relative-smaller-absolute)
-   [Semaglutide and Effort in Major Depression: A 72-Person Randomized Trial Evidence](https://thisglp.com/research/motivation-in-depression-a-secondary-finding)
-   [Obesity Drugs Ranked Across 262 Trials: Weight Lost vs Side-Effect Dropout Evidence](https://thisglp.com/research/the-best-losers-are-the-worst-tolerated)
-   [Do GLP-1 Drugs Help Psoriasis? Clear Skin in 40.6% Against 29.0%Evidence](https://thisglp.com/research/do-glp1-drugs-help-psoriasis)
-   [Do GLP-1 Drugs Cause Glaucoma? Nobody Untreated Was Ever Compared Safety](https://thisglp.com/research/do-glp1-drugs-cause-glaucoma)
-   [Frailty and Semaglutide's Cardiovascular Benefit in the SELECT Trial Evidence](https://thisglp.com/research/frailty-did-not-change-the-answer)
-   [BMI Above 30 and Type 2 Diabetes Drug Response: Weight vs HbA1c Evidence](https://thisglp.com/research/does-starting-weight-change-the-answer)
-   [Do GLP-1 Drugs Affect Breast Surgery? Implants Fared Worse, Flaps Did Not Evidence](https://thisglp.com/research/do-glp1-drugs-affect-breast-surgery)
-   [What Weight Loss Drugs Are There Besides Ozempic? Six Have Evidence Evidence](https://thisglp.com/research/what-weight-loss-drugs-are-there-besides-ozempic)
-   [Do GLP-1 Drugs Help Resistant Hypertension? The Pressure Matched Evidence](https://thisglp.com/research/do-glp1-drugs-help-resistant-hypertension)
-   [Do GLP-1 Drugs Help COPD? Fewer Flare-Ups, Against One Comparator Evidence](https://thisglp.com/research/do-glp1-drugs-help-copd)
-   [GLP-1 Drugs in Psoriasis: Mortality, Heart Events and Substance Use Evidence](https://thisglp.com/research/glp1-psoriasis-comorbidities)
-   [Semaglutide and Reproductive Hormones in Rats: A Pair-Fed Study Evidence](https://thisglp.com/research/semaglutide-reproduction-pair-fed-rats)
-   [Tirzepatide and Cardiac Remodeling in HFpEF: A 50-Patient Echo Study Evidence](https://thisglp.com/research/tirzepatide-hfpef-reverse-remodeling)
-   [Smart Scale Body Composition on GLP-1 Drugs: Fat vs Muscle Lost Evidence](https://thisglp.com/research/glp1-body-composition-smart-scale)
-   [Do GLP-1 Drugs Improve Blood Vessel Function? The Same Number, Two Answers Evidence](https://thisglp.com/research/do-glp1-drugs-improve-blood-vessel-function)
-   [Frailty and Semaglutide in Heart Failure: The STEP-HFpEF Analysis Evidence](https://thisglp.com/research/glp1-heart-failure-frailty)
-   [Liver Cancer Risk on GLP-1 Drugs vs Other Diabetes Treatments Evidence](https://thisglp.com/research/glp1-liver-cancer-absolute-risk)
-   [GLP-1 Drugs in MASH: Deaths, Ascites and a Small Liver Cancer Signal Evidence](https://thisglp.com/research/glp1-liver-cancer-signal-dismissed)
-   [Can You Take a GLP-1 on Dialysis? 2,492 Patients, and No Trial Evidence](https://thisglp.com/research/can-you-take-a-glp1-on-dialysis)
-   [Do GLP-1 Drugs Cause Pancreatic Cancer? Six Comparators, Five Answers Evidence](https://thisglp.com/research/do-glp1-drugs-cause-pancreatic-cancer)
-   [Do GLP-1 Drugs Help Parkinson's Disease? Prevention and Treatment Disagree Evidence](https://thisglp.com/research/do-glp1-drugs-help-parkinsons-disease)
-   [GLP-1 Prescribing to Children Aged 8 to 11: Who Gets Them Evidence](https://thisglp.com/research/glp1-prescriptions-to-young-children)
-   [Real-World GLP-1 Weight Loss: Discontinuation, Dose and the Trial Gap Evidence](https://thisglp.com/research/glp1-weight-loss-in-ordinary-care)
-   [How Do You Take Oral Semaglutide? Empty Stomach, and Little Water Formats](https://thisglp.com/research/how-do-you-take-oral-semaglutide)
-   [Oral Semaglutide 50 mg in East Asian Adults: 14.3% Weight Loss Evidence](https://thisglp.com/research/oral-semaglutide-fifty-milligrams)
-   [What Is Orforglipron? A Daily GLP-1 Tablet That Is Not a Peptide Evidence](https://thisglp.com/research/what-is-orforglipron)
-   [Do GLP-1 Drugs Help Heart Failure? Symptom Scores Rose 7.5 Points Evidence](https://thisglp.com/research/do-glp1-drugs-help-heart-failure)
-   [Semaglutide and Fracture Risk: Type 2 Diabetes vs No Diabetes Evidence](https://thisglp.com/research/semaglutide-fractures-diabetes-only)
-   [Semaglutide in Knee Osteoarthritis: A Six-Month Cohort and Its Phenotypes Evidence](https://thisglp.com/research/semaglutide-knee-osteoarthritis-phenotypes)
-   [Semaglutide and Handgrip Strength: A 12-Month Body Composition Study Evidence](https://thisglp.com/research/semaglutide-muscle-mass-and-grip)
-   [Semaglutide and NAION: Optic Nerve Risk in Diabetes vs Obesity Safety](https://thisglp.com/research/semaglutide-optic-nerve-by-indication)
-   [Is a Higher Semaglutide Dose Worth It? Three Points, Four Times the Symptom Evidence](https://thisglp.com/research/is-a-higher-semaglutide-dose-worth-it)
-   [What Else Comes Back When You Stop a GLP-1? Almost Everything Evidence](https://thisglp.com/research/what-else-comes-back-when-you-stop-a-glp1)
-   [Tirzepatide Dispensing by Dose in Japan: National Claims Data Formats](https://thisglp.com/research/tirzepatide-dose-mix-in-japan)
-   [SUMMIT Trial Composite Endpoint: Tirzepatide in HFpEF, Broken Down Evidence](https://thisglp.com/research/tirzepatide-heart-failure-composite)
-   [Tirzepatide vs Semaglutide: Major Adverse Liver Outcomes in Type 2 Diabetes Evidence](https://thisglp.com/research/tirzepatide-vs-semaglutide-liver)
-   [UBT251 Triple Agonist: First-in-Human 12-Week Weight Loss Trial Evidence](https://thisglp.com/research/triple-agonist-first-in-human)
-   [Do GLP-1 Drugs Cause Kidney Cancer? Trials Say Probably Not Safety](https://thisglp.com/research/do-glp1-drugs-cause-kidney-cancer)
-   [Gallstone Risk on GLP-1 Drugs: Weight-Loss vs Diabetes Trials Safety](https://thisglp.com/research/glp1-and-gallbladder-disease)
-   [Do GLP-1 Drugs Help Knee Pain? Yes, and Read the Placebo Arm Evidence](https://thisglp.com/research/do-glp1-drugs-help-knee-pain)
-   [Do GLP-1 Drugs Cause Pancreatitis? Risk and Warning Signs Safety](https://thisglp.com/research/do-glp1-drugs-cause-pancreatitis)
-   [Do GLP-1 Drugs Affect Sex Drive? Nobody Has Run That Trial Safety](https://thisglp.com/research/do-glp1-drugs-affect-sex-drive)
-   [Tirzepatide Sleep Apnea Trial (SURMOUNT-OSA): AHI Results at 52 Weeks Evidence](https://thisglp.com/research/glp1-and-sleep-apnea)
-   [Residual Stomach Contents on GLP-1 Drugs: A Gastric Ultrasound Study Safety](https://thisglp.com/research/glp1-before-surgery)
-   [Semaglutide Lean Mass in the SMART Trial: −2.5 kg, Interval Crossing Zero Evidence](https://thisglp.com/research/muscle-loss-on-glp1)
-   [FLOW Trial: Semaglutide 1.0 mg in Diabetic Chronic Kidney Disease Evidence](https://thisglp.com/research/semaglutide-and-kidney-disease)
-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded Evidence](https://thisglp.com/research/semaglutide-cochrane-review)
-   [Tirzepatide and Oral Contraceptive Levels: 55 to 66% Lower Peaks Safety](https://thisglp.com/research/tirzepatide-and-oral-contraception)
-   [GLP-1 Seller Disclosure Gaps: Dose Pricing, State Coverage, Formats Formats](https://thisglp.com/research/what-glp1-sellers-do-not-publish)
-   [GLP-1 Sellers That Publish a Dose Price Ladder, Counted Formats](https://thisglp.com/research/who-publishes-a-glp1-dose-ladder)

[Browse all research](https://thisglp.com/research)[About This GLP](https://thisglp.com/about)
